Asia-Pacific electrophysiology (EP) market, is set to experience rapid growth in value over the coming years, climbing from approximately $0.77 billion in 2016 to $1.05 billion by 2021, at a Compound Annual Growth Rate (CAGR) of 9%.
The Asia-Pacific electrophysiology (EP) market, consisting of ablation catheters, diagnostic catheters and lab systems.
The growth of the Asia- Pacific Electrophysiology market is driven by several factors, the most important of which is the technological innovations. Technological innovations and advancements have led to the introduction of new products . The other factors promoting the growth of the market are increasing incidences of chronic diseases, , ease of use and interpretation of medical devices. Factors constraining the growth of the market include reimbursement issues, high cost of the medical devices .Emerging economies, Public awareness for cardiac disease are the major opportunities in the market.
The report segments the market by types( Electrophysiology monitoring devices, Treatment devices) and based on geography(India, China, Japan)Asia-Pacific shows very potential market due to increasing technological innovations, and increasing per capita income and growing economy.
Major companies discussed in this report with their profile and relevant information from market perspective are Abbott Laboratories, Biotronik SE & Co. KG, Boston Scientific, GE Healthcare, Johnson & Johnson, Medtronic Inc., Microport
What makes our report unique??
1) An extensive research study on the Electrophysiology market, and its entire ecosystem, describes the market trends, drivers, restraints and opportunities of the wearable electronics.
2) We provide the longest segmentation of the market based on products, technology, components, form factor, products application, industry verticals, and geography.
3) This report gives a birds eye-view of the market competitive landscape which includes mergers & acquisitions, collaborations., new product launches and key players in the market.